Error: Could not add to watchlist. X
+ Watchlist

COSMO Pharmaceuticals NV

CMOPF:US
OTC US
147.78
USD
0.00
0.00%
As of 8:10 PM EDT 8/10/2017
Volume
43
Previous Close
147.78
52Wk Range
147.78 - 160.68
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
43
Previous Close
147.78
52Wk Range
147.78 - 160.68
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-
Market Cap (b USD)
2.222
Shares Outstanding (m)
15.037
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
1.13%
Sector
Health Care
% Price Change
-0.20%
% Price Change
+0.24%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Cosmo Pharmaceuticals NV develops and manufactures therapies for gastrointestinal diseases. The Company's proprietary technology delays the delivery of the active drug mainly into the lumen of the colon. Cosmo develops treatments for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and for colon infections.
Address
Riverside II
Sir John Rogerson₣ 1/64 13/32s Quai
Dublin 2
Ireland
Phone
352-2784-8749
Show More